AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 14724665
Drug: Sibutramine 10
RxNorm normalized name: sibutramine 10 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine 10 mg/day plus metoprolol 25 mg/day (group M)
Trial: 14724665
Drug: Sibutramine 10
RxNorm normalized name: sibutramine 10 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine 10 mg/day plus placebo (group P)
Trial: 9278651
Drug: Enoxaparin, 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin, 40 mg once daily, beginning 2 hours before surgery
Trial: 9278651
Drug: Unfractionated low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Unfractionated low-dose heparin, three times daily
Trial: 8314960
Drug: 1.0 ng/ml
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 ng/ml EGF
Trial: 8314960
Drug: 10.0 ng/ml
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10.0 ng/ml EGF
Trial: 3578401
Drug: Low-dose oral
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose oral contraceptive preparations (seven types)
Trial: 29112070
Drug: Ritonavir-boosted protease
RxNorm normalized name: Ritonavir
DrugBank: Ritonavir (DB00503)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ritonavir-boosted protease inhibitor (PI/r)
Trial: 26261074
Drug: 200 U
RxNorm normalized name: lipase 1200 UNT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 U BTX‐A intradetrusor injections excluding the trigone (Control group)
Trial: 26261074
Drug: 160 U
RxNorm normalized name: hyaluronidase, human recombinant 160 UNT/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 160 U intradetrusor and 40 U intratrigonal injections (Experimental group)
Trial: 8024910
Drug: ACE inhibitor
RxNorm normalized name: ACE INHIBITORS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE inhibitor (ramipril)
Trial: 12864879
Drug: Dihydropyridine calcium
RxNorm normalized name: 4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsäuredimethylester
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dihydropyridine calcium channel blocker (DHP-CCB, amlodipine)
Trial: 12819322
Drug: Beta-blocker (metoprolol)
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blocker (metoprolol)
Trial: 11472003
Drug: Sequential mode
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential mode ablation technique
Trial: 15640848
Drug: Influenza split
RxNorm normalized name: INFLUENZA SPLIT VIRUS '95-'96 VIL 5ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Influenza split vaccine
Trial: 9258527
Drug: Influenza split
RxNorm normalized name: INFLUENZA SPLIT VIRUS '95-'96 VIL 5ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Influenza split vaccine + Pneumococcal 23-valent vaccine
Trial: 9258527
Drug: Pneumococcal 23-valent
RxNorm normalized name: Pneumococcal 23-valent vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pneumococcal 23-valent vaccine (administered simultaneously with influenza vaccine)
Trial: 9258527
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (Influenza vaccine alone)
Trial: 7943888
Drug: Film-forming preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Film-forming preparation 'Lifusol' for catheter fixation
Trial: 2945783
Drug: Synthetic human
RxNorm normalized name: Synthetic human secretin
DrugBank: Secretin human (DB09532)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Synthetic human atrial natriuretic peptide (i.v. bolus of 25 micrograms followed by a 6‐hour infusion of 25 micrograms/hr)
Trial: 2945783
Drug: Synthetic human
RxNorm normalized name: Synthetic human secretin
DrugBank: Secretin human (DB09532)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Synthetic human atrial natriuretic peptide (i.v. bolus of 175 micrograms followed by a 6‐hour infusion of 100 micrograms/hr)
Trial: 26742001
Drug: Live Attenuated
RxNorm normalized name: mumps, live attenuated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Live Attenuated Influenza Vaccine (LAIV), administered to 77 children, analyzed 63 children after vaccination.
Trial: 21985488
Drug: Pentoxifylline (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (800 mg/day, intravenous infusion and oral supplementation)
Trial: 19671203
Drug: Capsinoids (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsinoids (1 mg)
Trial: 19671203
Drug: Capsinoids (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsinoids (3 mg)
Trial: 19671203
Drug: Capsinoids (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsinoids (6 mg)
Trial: 29381803
Drug: Capsinoids (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsinoids (12 mg)
Trial: 15838406
Drug: Medical care
RxNorm normalized name: benzethonium Medicated Liquid Soap [Bedside-Care]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical care with physical therapy (MDPt)
Trial: 9609609
Drug: Intravenous aminophylline
RxNorm normalized name: Aminophylline
DrugBank: Aminophylline (DB01223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous aminophylline therapy
Trial: 1315825
Drug: Candoxatril 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candoxatril 200 mg
Trial: 31147306
Drug: Intra-aortic balloon
RxNorm normalized name: somatropin
DrugBank: Somatotropin (DB00052)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intra-aortic balloon pump (IABP) 50 mL
Trial: 20227053
Drug: Rescue antenatal
RxNorm normalized name: ALLERGENIC EXTRACT, MEADOW FESCUE POLLEN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rescue antenatal steroids
Trial: 26459347
Drug: General anesthesia
RxNorm normalized name: Ethers for general anesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General anesthesia plus postoperative intravenous analgesia
Trial: 21212157
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg BIBF 1120 b.i.d.
Trial: 21212157
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg BIBF 1120 b.i.d.
Trial: 21212157
Drug: BIBF 1120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BIBF 1120 (both doses)
Trial: 15153206
Drug: Double-breath (DB)
RxNorm normalized name: cetylpyridinium chloride Mouthwash [Breath-Away]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double-breath (DB) VC inhalation induction with 8% sevoflurane in 66% nitrous oxide
Trial: 15153206
Drug: Single-breath (SB)
RxNorm normalized name: cetylpyridinium chloride Mouthwash [Breath-Away]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-breath (SB) VC inhalation induction with 8% sevoflurane in 66% nitrous oxide
Trial: 11409130
Drug: Glucosamine sulfate
RxNorm normalized name: Glucosamine Sulfate
DrugBank: Glucosamine (DB01296)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glucosamine sulfate (GS) 500 mg tid
Trial: 11409130
Drug: Ibuprofen 400
RxNorm normalized name: ibuprofen 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 400 mg tid
Trial: 9773910
Drug: Oral prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral prednisone (2 mg/kg/day) for 3 days
Trial: 1662885
Drug: Ceftriaxone 250
RxNorm normalized name: ceftriaxone 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone 250 mg
Trial: 3079005
Drug: Defibrotide (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Defibrotide (400 mg twice daily, administered intramuscularly)
Trial: 3079005
Drug: Calcium heparin
RxNorm normalized name: HEPARIN CALCIUM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium heparin (5,000 IU thrice daily, administered subcutaneously)
Trial: 3079005
Drug: ASA (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASA (100 mg on alternate days, administered orally)
Trial: 3113147
Drug: Naloxone administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone administration
Trial: 31899878
Drug: Subcutaneous sumatriptan
RxNorm normalized name: Sumatriptan
DrugBank: Sumatriptan (DB00669)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous sumatriptan administration
Trial: 31899878
Drug: No sumatriptan
RxNorm normalized name: Sumatriptan
DrugBank: Sumatriptan (DB00669)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No sumatriptan administration (Control)
Trial: 25733626
Drug: Plant sterols
RxNorm normalized name: Plant Sterols/Stanol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plant sterols (PS) consumption (2 g PS/d for 28 days)
Trial: 25733626
Drug: Plant sterols
RxNorm normalized name: Plant Sterols/Stanol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plant sterols (PS) consumption (2 g PS/d for 28 days) in LS individuals
Trial: 25733626
Drug: Plant sterols
RxNorm normalized name: Plant Sterols/Stanol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plant sterols (PS) consumption (2 g PS/d for 28 days) in HS individuals
Trial: 25733626
Drug: Plant sterols
RxNorm normalized name: Plant Sterols/Stanol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plant sterols (PS) consumption (2 g PS/d for 28 days) in LS participants
Trial: 23256446
Drug: 12‐week honey
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12‐week honey consumption (0.5 mL/kg body weight per day)
Trial: 15620485
Drug: Swanson implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Swanson implants
Trial: 17065118
Drug: NeuFlex implants
RxNorm normalized name: camphor
DrugBank: Camphor (DB01744)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NeuFlex implants
Trial: 16493482
Drug: Otamixaban (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Otamixaban (0.3 mg/kg)
Trial: 16493482
Drug: Otamixaban (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Otamixaban (0.5 mg/kg)
Trial: 16493482
Drug: Otamixaban (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Otamixaban (0.3 mg/kg) with ASA (300 mg once a day)
Trial: 16493482
Drug: Otamixaban (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Otamixaban (0.5 mg/kg) with ASA (300 mg once a day)
Trial: 16493482
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA) (300 mg once a day)
Trial: 2455840
Drug: Xamoterol, 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xamoterol, 200 mg
Trial: 2455840
Drug: Prenalterol, 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prenalterol, 50 mg
Trial: 2455840
Drug: Salbutamol, 8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salbutamol, 8 mg
Trial: 2455840
Drug: ICI 118,551,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICI 118,551, 25 mg with Xamoterol
Trial: 2455840
Drug: ICI 118,551,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICI 118,551, 25 mg with Prenalterol
Trial: 2455840
Drug: ICI 118,551,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICI 118,551, 25 mg with Salbutamol
Trial: 25514106
Drug: Denosumab, 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Denosumab, 60 mg s.c. every 6 months
Trial: 25514106
Drug: Oral bisphosphonates
RxNorm normalized name: methylene diphosphonate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral bisphosphonates (ibandronate or risedronate, 150 mg once monthly for 12 months)
Trial: 14984226
Drug: zolmitriptan 2.5
RxNorm normalized name: zolmitriptan 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: zolmitriptan 2.5 mg
Trial: 15259834
Drug: Citalopram, 20
RxNorm normalized name: Escitalopram, 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram, 20 mg/day
Trial: 9125637
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg capsule with water
Trial: 9125637
Drug: Omeprazole granules
RxNorm normalized name: omeprazole Granules for Oral Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole granules with Alka-Seltzer solution
Trial: 8238221
Drug: Carteolol 1.0%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carteolol 1.0% (one drop twice daily in both eyes)
Trial: 8238221
Drug: Timolol 0.5%
RxNorm normalized name: Timolol 0.5% Ophthalmic Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timolol 0.5% (one drop twice daily in both eyes)
Trial: 3517284
Drug: Cholestyramine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholestyramine (4 g/d)
Trial: 3517284
Drug: Phenobarbital (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenobarbital (7.5 to 10 mg/kg/d)
Trial: 30425469
Drug: CHF6001 (20,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHF6001 (20, 100, 200, 400, 800, 1,600, and 2,000 µg) via SDDPI
Trial: 30425469
Drug: CHF6001 (2,400,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHF6001 (2,400, 4,000, and 4,800 µg) via MDDPI
Trial: 30425469
Drug: CHF6001 (100,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHF6001 (100, 300, 600, 1,200, and 1,600 µg) once daily via SDDPI
Trial: 30425469
Drug: CHF6001 (1,200,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHF6001 (1,200, 2,000, or 2,400 µg) twice daily via MDDPI
Trial: 17852636
Drug: Methotrexate (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methotrexate (15 mg) + Betamethasone (3 mg) weekly
Trial: 17852636
Drug: Methotrexate (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methotrexate (15 mg) weekly
Trial: 16051542
Drug: Qi-therapy (external
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Qi-therapy (external Qigong) for four weeks
Trial: 16051542
Drug: Qi-therapy (external
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Qi-therapy (external Qigong)
Trial: 10024861
Drug: Staples, close
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Staples, close after protamine administration
Trial: 11563407
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg oral fosinopril
Trial: 11563407
Drug: 7.5 mg
RxNorm normalized name: biotin 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 mg IV fosinoprilat
Trial: 1854169
Drug: Ciprofloxacin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin (200 to 300 mg every 12 h)
Trial: 6364886
Drug: Mesterolone (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mesterolone (75 mg/day)
Trial: 10335764
Drug: Low-dose atorvastatin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose atorvastatin (20 mg)
Trial: 26147898
Drug: Ethanol at
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ethanol at BAC of approximately 0.5 g/L
Trial: 26147898
Drug: Ethanol at
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ethanol at BAC of approximately 0.9 g/L
Trial: 26147898
Drug: Sober condition
RxNorm normalized name: suberic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sober condition (0 g/L BAC)
Trial: 23567376
Drug: Telehealth problem-solving
RxNorm normalized name: Solv X
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telehealth problem-solving therapy (tele-PST)
Trial: 22819521
Drug: Budesonide 800
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide 800 μg/d
Trial: 22819521
Drug: Budesonide 400
RxNorm normalized name: Budesonide 400 microgram/actuation powder for inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide 400 μg/d plus montelukast 10 mg/d
Trial: 17894791
Drug: Augmented transfusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Augmented transfusion strategy (transfusion of 2 units of RBCs when Hb < 120 g/L)
Trial: 17894791
Drug: Standard transfusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard transfusion strategy (transfusion of 2 units of RBCs when Hb < 80 g/L)
Trial: 10486649
Drug: No estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No estrogen replacement therapy (Control)
Trial: 8564101
Drug: Terbutaline 7.5
RxNorm normalized name: terbutaline 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline 7.5 mg twice a day for 2 weeks
Trial: 8564101
Drug: Budesonide 400
RxNorm normalized name: Budesonide 400 microgram/actuation powder for inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide 400 micrograms twice a day by inhalation
Trial: 8564101
Drug: Prednisolone 40
RxNorm normalized name: prednisolone 40 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone 40 mg orally 12 h before second examination
Trial: 8564101
Drug: Terbutaline treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline treatment
Trial: 1920340
Drug: Nifedipine AR
RxNorm normalized name: nifedipine Extended Release Oral Tablet [Adalat AR]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine AR (20 mg twice daily)
Trial: 1920340
Drug: Placebo (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (1 tab twice daily)
Trial: 31792485
Drug: Combined orthodontic
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined orthodontic treatment and conventional periodontal splint (experimental group)
Trial: 19852337
Drug: Elective re-siting
RxNorm normalized name: Re-Covr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elective re-siting of intravenous cannulae every 48 hours
Trial: 17572322
Drug: 1-minute group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-minute group (2 L/min oxygen and 4 L/min nitrous oxide for 1 minute)
Trial: 17572322
Drug: 2-minute group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-minute group (2 L/min oxygen and 4 L/min nitrous oxide for 2 minutes)
Trial: 17572322
Drug: 3-minute group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-minute group (2 L/min oxygen and 4 L/min nitrous oxide for 3 minutes)
Trial: 17572322
Drug: 5-minute group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-minute group (2 L/min oxygen and 4 L/min nitrous oxide for 5 minutes)
Trial: 12199264
Drug: Gabapentin (1,800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin (1,800 to 3,600 mg/day)
Trial: 9667260
Drug: Carboplatin AUC
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Carboplatin AUC 6 for six courses, administered every 28 days
Trial: 9667260
Drug: Carboplatin AUC
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Carboplatin AUC 12 for four courses, administered every 28 days
Trial: 15374499
Drug: Centrophenoxine (CPH),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Centrophenoxine (CPH), 2 g/day for 8 weeks
Trial: 30426525
Drug: Hand cream
RxNorm normalized name: TETRIX HAND CREAM,TOP
DrugBank: Triclosan (DB08604)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hand cream dispensers equipped with an electronic system to monitor use, communicated regularly to HCWs via posters.
Trial: 25743732
Drug: Muscle strength
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Muscle strength training program (50 minutes, twice a week for 8 weeks, including Kegel's exercise, Thera-band training, and indoor walking)
Trial: 19699385
Drug: High-dose N-acetylcysteine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose N-acetylcysteine (daily dose > 1200 mg or single dose > 600 mg within 4 hours of contrast exposure)
Trial: 15211249
Drug: Amoxicillin-clavulanic acid
RxNorm normalized name: amoxicillin / clavulanate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin-clavulanic acid administered for 7 days
Trial: 21078196
Drug: Child-focused cognitive-behavioral
RxNorm normalized name: Senna-Relief Childs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Child-focused cognitive-behavioral therapy (CBT)
Trial: 9874902
Drug: Child-focused cognitive-behavioral
RxNorm normalized name: Senna-Relief Childs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Child-focused cognitive-behavioral therapy (CBT) plus parental anxiety management (CBT + PAM)
Trial: 9874902
Drug: Child-focused cognitive-behavioral
RxNorm normalized name: Senna-Relief Childs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Child-focused cognitive-behavioral therapy (CBT + PAM)
Trial: 7979494
Drug: Nebuhaler (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebuhaler (750 ml)
Trial: 7979494
Drug: Aerochamber (140
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerochamber (140 ml)
Trial: 7979494
Drug: Babyspacer (260
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Babyspacer (260 ml)
Trial: 403557
Drug: Propranolol (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (120 mg per os)
Trial: 403557
Drug: Marihuana (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marihuana (10 mg delta9-THC)
Trial: 14705107
Drug: Spinal cord
RxNorm normalized name: BOS TAURUS SPINAL CORD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal cord stimulation and physical therapy (SCS+PT)
Trial: 9259358
Drug: Increased dialysis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased dialysis volume (0.5 L per exchange, total increase of 1.5 L daily)
Trial: 9259358
Drug: Unchanged dialysis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unchanged dialysis regimen (4 exchanges of 2 L per day)
Trial: 8279841
Drug: 50 mg/day
RxNorm normalized name: infigratinib phosphate 50 mg/day (25 mg x 2) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg/day of cyclophosphamide for 3 months
Trial: 8279841
Drug: Cyclophosphamide 500
RxNorm normalized name: cyclophosphamide 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclophosphamide 500 mg/m2 + CDDP 75 mg/m2 every 4 weeks for 3 courses